James J. Burns & Company’s Akebia Therapeutics AKBA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.9K	Hold	11,448	–	–	﹤0.01%	155
2025 Q4	$18.4K	Sell	11,448 -300	-3%	-$628	﹤0.01%	161
2025 Q3	$32.1K	Hold	11,748	–	–	﹤0.01%	159
2025 Q2	$42.8K	Hold	11,748	–	–	0.01%	155
2025 Q1	$22.6K	Sell	11,748 -754	-6%	-$1.54K	﹤0.01%	143
2024 Q4	$24K	Sell	12,502 -3,100	-20%	-$5.38K	﹤0.01%	147
2024 Q3	$21K	Hold	15,602	–	–	﹤0.01%	141
2024 Q2	$16K	Hold	15,602	–	–	﹤0.01%	128
2024 Q1	$25K	Sell	15,602 -2,800	-15%	-$4.48K	0.01%	85
2023 Q4	$23K	Sell	18,402 -6,140	-25%	-$6.26K	0.01%	120
2023 Q3	$28K	Sell	24,542 -600	-2%	-$771	0.01%	104
2023 Q2	$23K	Hold	25,142	–	–	0.01%	113
2023 Q1	$14K	Hold	25,142	–	–	﹤0.01%	112
2022 Q4	$15K	Hold	25,142	–	–	0.01%	79
2022 Q3	$8K	Buy	+25,142	New	+$9.87K	﹤0.01%	79